U.S. market Open. Closes in 1 hour 7 minutes

RCKT | Rocket Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cost of Revenue7.10M6.27M5.37M1.15M426.00KN/AN/AN/AN/AN/AN/AN/A
Gross Profit-7.10M-6.27M-5.37M-1.15M-426.00KN/AN/AN/AN/AN/AN/AN/A
Operating Expenses249.01M223.84M166.25M134.30M75.90M70.97M26.74M41.88M20.40MN/AN/AN/A
Selling, General & Admin73.32M58.77M41.77M27.92M17.53M17.89M12.54M9.89M7.84M2.11M1.32M2.31M
Research & Development186.34M165.57M125.48M106.38M58.62M53.27M14.19M31.98M12.55M5.59M5.33M3.54M
Other Operating ExpensesN/A-500.00K-1.00MN/A-250.00K186.00KN/AN/AN/AN/AN/AN/A
Operating Income-259.66M-224.34M-167.25M-134.30M-76.15M-71.16M-26.74M-41.88M-20.40M-7.70M-6.65M-5.85M
Other Expenses / Income14.06M2.48M-1.82M-5.40M-1.12M801.00K-2.76M-975.00K-47.59M-1.83M-962.00K-209.00K
Before Tax Income-245.59M-221.86M-169.07M-139.70M-77.27M-74.52M-29.50M-42.85M-67.98M-9.53M-7.62M-6.06M
Income Tax ExpensesN/A-2.48M516.00K6.97M5.96M2.68MN/AN/AN/AN/AN/AN/A
Net Income-245.59M-219.38M-169.59M-146.67M-83.23M-74.52M-29.50M-42.85M-67.98M-9.53M-7.62M-6.06M
Interest Expenses1.88M1.91M5.89M7.55M4.78M5.24M3.58M1.42M1.23M980.00K884.00K213.00K
Basic Shares Outstanding84.01M68.15M63.24M55.38M49.01M39.38M6.77M6.68M4.58M3.42M1.81M2.10M
Diluted Shares Outstanding84.01M68.15M63.24M55.38M49.01M39.38M6.77M6.68M4.58M3.42M1.81M2.10M
EBITDA-252.56M-213.69M-163.18M-131.01M-72.06M-68.95M-25.72M-41.71M-20.35M-7.70M-6.65M-5.84M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-243.72M-219.95M-163.18M-132.15M-72.49M-66.60M-25.92M-41.44M-66.75M-8.55M-6.73M-5.84M
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙